Connect with us

Technology

Sandler Partners and Liminal Announce Strategic Partnership to Bring Secure Generative AI Solutions to Enterprise Customers Nationwide

Published

1 hour ago

on

This new partnership gives Sandler Partners’ extensive network of technology experts access to Liminal’s enterprise AI governance and enablement platform.

REDONDO BEACH, Calif., July 15, 2026 /PRNewswire/ — Sandler Partners, the nation’s leading independent technology distributor, today announced a strategic partnership with Liminal, the company behind the leading secure AI governance and enablement platform for enterprises. This collaboration enables Sandler Partners’ network of more than 10,000 trusted technology experts to offer Liminal’s powerful platform to organizations looking to empower their workforce with the latest AI tools while maintaining total control over data security, governance, and visibility.

As organizations across industries look to accelerate their adoption of AI tools, the need for robust security, data protection, and policy enforcement has become critical. With Liminal, Partners can offer their clients unlimited, secure access to all the latest models from OpenAI, Anthropic, Google, and others, plus the ability to safely leverage internal data in AI interactions. At the same time, the platform delivers the comprehensive data security, governance, and observability organizations demand. The result: organizations can move fast on AI without sacrificing control.

“Our goal is to equip Partners with the solutions, expertise, and resources they need to effectively lead strategic technology conversations with their clients,” said Ryan Yakos, SVP, Channel – Midwest. “Liminal expands our AI portfolio with a differentiated platform that addresses a rapidly growing area of customer interest. We’re excited to provide our Partners with another innovative solution that helps them create value and drive meaningful business outcomes.”

“We’re thrilled to partner with Sandler Partners to extend the reach of our AI governance platform,” said Michelle Eatherton, Chief Business Officer at Liminal. “With a proven track record of delivering best-in-class technology solutions through their network of 10,000+ expert agents and advisors, Sandler is an ideal partner to help us empower more enterprises to adopt generative AI securely and responsibly.”

This collaboration reflects both companies’ commitment to helping businesses navigate AI adoption while maintaining security and control.

About Sandler Partners

Sandler Partners helps empower its network of leading independent Sales Partners to deliver a comprehensive range of technology solutions to organizations worldwide, including Cybersecurity, Artificial Intelligence (AI), Connectivity, Cloud, Colocation, Mobility, Internet of Things (IoT), and Continuity. Its community-focused approach enables Partners to identify the right solutions for customers quickly and objectively from a diverse portfolio of 220+ Providers.

Partner sales agents, VARs, and MSPs gain access to an innovative suite of sales tools within the Sandler Portal—including SCOUT, Solutions Finder, Scout for Solutions, and the Marketing Center—several of which are AI-powered, all backed by a robust support network, dedicated Sales Engineering expertise, and rich marketing resources. Together, these tools and resources empower Partners to focus on what they do best: delivering quality, value, performance, innovative solutions, unmatched expertise, and exceptional service to their clients.

Members of the Sandler Partners community also benefit from the industry’s strongest negotiated agreements and a dedicated team committed to ensuring commissions are accurately identified, tracked, and paid. For more information, visit www.sandlerpartners.com.

About Liminal

Liminal is the secure, flexible, cost effective way organizations deploy generative AI.  With Liminal, regulated enterprises are able to experience the productivity benefits of AI, while enjoying world-class data protection, governance, and observability capabilities – all delivered with unparalleled cost efficiency. For more information, visit www.liminal.ai.

Media Contacts:

Sandler Partners
Tina S. Dyksterhouse
tina@sandlerpartners.com 
310.796.1393

Liminal
Marc Jacocks
marc@liminal.ai 
303.578.6415

View original content to download multimedia:https://www.prnewswire.com/news-releases/sandler-partners-and-liminal-announce-strategic-partnership-to-bring-secure-generative-ai-solutions-to-enterprise-customers-nationwide-302826788.html

SOURCE Sandler Partners

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment

Published

14 minutes ago

on

July 15, 2026

By

WASHINGTON, July 15, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that NEREUS™ (tradipitant), the first new prescription medication approved for prevention of vomiting induced by motion in 47 years, will sponsor the No. 47 entry in the NTT IndyCar Series with Rahal Letterman Lanigan Racing.

The partnership aligns NEREUS’™ breakthrough innovation in motion relief with the high-speed world of IndyCar racing, where focus and stability are essential.

This sponsorship marks a symbolic milestone: 47 years since the last new motion sickness treatment was introduced in the United States. NEREUS™ represents a modern advancement as a selective NK-1 receptor antagonist designed to prevent vomiting induced by motion, offering a new option for millions who experience motion sickness during travel.

“Partnering with the No. 47 car perfectly captures this historic moment and our shared commitment to performance under challenging conditions,” said Mihael H. Polymeropoulos, M.D., President, CEO and Chairman of the Board of Vanda. 

The NEREUS™-branded No. 47 IndyCar will feature prominent sponsorship visibility across select NTT IndyCar Series events in 2026.

About NEREUS™ (tradipitant)

NEREUS™ is an oral NK-1 receptor antagonist FDA-approved for the prevention of vomiting induced by motion in adults. It is the first new pharmacologic treatment approved for this indication in over four decades.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

About Rahal Letterman Lanigan Racing

Rahal Letterman Lanigan Racing is a championship-winning team competing in the NTT IndyCar Series.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

Follow us on X @vandapharma

View original content to download multimedia:https://www.prnewswire.com/news-releases/nereus-powers-forward-sponsors-no-47-indycar-entry-celebrating-47-years-since-last-new-us-motion-sickness-treatment-302826721.html

SOURCE Vanda Pharmaceuticals Inc.

Continue Reading

Technology

VIAVI Announces Date for Fiscal Fourth Quarter and Fiscal Year 2026 Financial Results

Published

14 minutes ago

on

July 15, 2026

By

CHANDLER, Ariz., July 15, 2026 /PRNewswire/ — Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) will announce its fiscal fourth quarter and fiscal year 2026 financial results for the period ended June 27, 2026, on Wednesday, August 5, 2026, after the close of market.

The Company will host an earnings call at 1:30 p.m. PT / 4:30 p.m. ET. A live webcast of the call and the replay will be available on the VIAVI website at https://investor.viavisolutions.com. The quarterly earnings press release, supplementary slides and historical financial tables will be posted under the “Quarterly Results” section.

To participate via telephone:

Toll-Free Dial-In Number:

1 (833) 461-5787

Toll Dial-In Number:

1 (585) 542-9983

Conference ID:

687 725 628

About VIAVI Solutions
VIAVI (NASDAQ: VIAV) is a global leader in test and measurement and optical technologies. Our test, monitoring, assurance, and resilient position, navigation and timing solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, we develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets.

Learn more about VIAVI at www.viavisolutions.com. Follow us on VIAVI Perspectives, LinkedIn and YouTube.

Investors Contact:
Vibhuti Nayar, 408-404-6305; investor.relations@viavisolutions.com
Press Contact:
Amit Malhotra, 202-341-8624; amit.malhotra@viavisolutions.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/viavi-announces-date-for-fiscal-fourth-quarter-and-fiscal-year-2026-financial-results-302822275.html

SOURCE VIAVI Financials

Continue Reading

Technology

The American Council of the Blind to Distribute Ray-Ban Meta AI Glasses to Blind Veterans in St. Louis on July 27

Published

14 minutes ago

on

July 15, 2026

By

ALEXANDRIA, Va., July 15, 2026 /PRNewswire/ — The American Council of the Blind is proud to partner with Meta and the Blinded Veterans Association (BVA) to distribute Ray-Ban Meta AI glasses to eligible veterans who are blind during the upcoming 2026 ACB Conference and Convention in St. Louis.

The distribution will take place on Monday, July 27, from 1 to 5 p.m. CT at the Hyatt St. Louis at The Arch in downtown St. Louis. Eligible veterans can receive Ray-Ban Meta AI glasses at no cost while supplies last and a complimentary day pass to the ACB convention for July 27.

The initiative is part of Meta’s commitment to donate Ray-Ban Meta AI glasses to 130,000 blinded veterans worldwide, expanding access to technology that can support greater independence, access to information, and everyday tasks. As a distribution partner, ACB will also provide access to training resources for veterans receiving Meta glasses.

“Supporting veterans who are blind or have low vision has long been an important part of ACB’s mission,” said ACB Executive Director Scott Thornhill. “We are honored to partner with Meta and BVA to help connect veterans with innovative technology that can make a meaningful difference in their daily lives.”

Ray-Ban Meta AI glasses combine a lightweight, hands-free design with built-in artificial intelligence to help users complete everyday tasks more independently. Wearers can ask the glasses to describe their surroundings, read printed text, identify objects, and capture photos or videos.

To receive a pair of Ray-Ban Meta AI glasses at the July 27 distribution event, individuals must provide proof of military service, acknowledge legal blindness, and own a compatible smart phone.

A day pass to the ACB Conference and Convention with access to the Exhibit Hall will be available for recipients.

For more details about the Ray-Ban Meta AI glasses distribution, visit https://www.acb.org/glasses.

About the American Council of the Blind

The American Council of the Blind is a national member-driven consumer organization representing Americans who are blind or have low vision. With 65 affiliates, ACB strives to increase independence, security, equality of opportunity, and to improve the quality of life for all people who are blind or have low vision. For more information, visit https://www.acb.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-american-council-of-the-blind-to-distribute-ray-ban-meta-ai-glasses-to-blind-veterans-in-st-louis-on-july-27-302826844.html

SOURCE American Council of the Blind

Continue Reading

Trending